40,000+ lives changed and counting
That’s living proof
The Intracept™ Procedure is the first and only procedure designed specifically to relieve vertebrogenic low back pain. As part of Boston Scientific, we are driving discovery and innovation in chronic low back pain. We’re here for you today and continue to invest in creating the future of pain relief.
Watch the video and see how the Intracept Procedure is transforming lives.
Proven safe, effective, and durable
The Intracept Procedure is the only vertebrogenic pain treatment supported by long-term clinical evidence, including two Level I Randomized Controlled Trials. Clear, rigorous, high-quality data—that’s living proof.
The next-generation Intracept™ System
Our purpose-built access instruments are designed for precision and predictability. We continue to advance the proven, safe, and durable Intracept Procedure with next-generation basivertebral nerve targeting.
Expert resources
We provide unparalleled resources and expertise from education and training to insurance and reimbursement support. We bring it all together to help build your Intracept program, and enable safe and effective patient outcomes.
Living proof: What physicians and patients are saying about the Intracept Procedure
“When you talk about a procedure like Intracept…we’re talking about game-changing pain relief.”
– Gregory Moore, MD
Awareness of this treatment is going to lead to more people getting treated and eventually getting better.”
– Jad G. Khalil, MD
Connect to living proof
Fill out this form to learn more about adding the Intracept Procedure to your practice or to get in touch with the Intracept team.
References
- Fischgrund JS, Rhyne A, Macadaeg K, et al. Long-term outcomes following intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: 5-year treatment arm results from a prospective randomized double-blind sham-controlled multi-center study. Eur Spine J. 2020;29(8):1925-1934. doi:org/10.1007/s00586-020-06448-x
- Khalil, J., et al. Intraosseous basivertebral nerve ablation: 5-year outcomes from three long-term follow-up studies. Interventional Pain Medicine, Volume 3, Issue 4, 2024,100529, ISSN 2772-5944, https://doi.org/10.1016/j.inpm.2024.100529.
Indications for Use: The Intracept™ Intraosseous Nerve Ablation System is intended to be used in conjunction with radiofrequency (RF) generators for the ablation of basivertebral nerves of the L3 through S1 vertebrae for the relief of chronic low back pain of at least six months duration that has not responded to at least six months of conservative care, and is also accompanied by features consistent with Type 1 or Type 2 Modic changes on an MRI such as inflammation, edema, vertebral endplate changes, disruption and fissuring of the endplate, vascularized fibrous tissues within the adjacent marrow, hypointensive signals (Type 1 Modic change), and changes to the vertebral body marrow including replacement of normal bone marrow by fat, and hyperintensive signals (Type 2 Modic change). Contraindications – Use of the Intracept Intraosseous Nerve Ablation System is contraindicated in: Patients with severe cardiac or pulmonary compromise, patients with active implantable pulse generators (e.g. pacemakers, defibrillators), patients where the targeted ablation zone is < 10 mm away from a sensitive structure not intended to be ablated, including the vertebral foramen (spinal canal), patients with active systemic infection or local infection in the area to be treated, patients who are pregnant, and/or skeletally immature patients (generally ≤ 18 years of age). Refer to the Instructions for Use provided with the Intracept Procedure or www.relievant.com/intracept/ for potential adverse effects, warnings, and precautions prior to using this product. Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
NM-2094003-AA